Status:

WITHDRAWN

NOWDx Test for the Diagnosis of Herpes Simplex Virus Type 2

Lead Sponsor:

NOWDiagnostics, Inc.

Conditions:

HSV-2 Infection

Herpes Simplex Virus Infection

Eligibility:

All Genders

18-64 years

Brief Summary

This study is designed to compare the performance of the NOWDx HSV-2 Test to a currently marketed device. The intent is to show the rapid test device is comparable to the currently marketed device. Th...

Detailed Description

The objective of this study is to establish the performance characteristics of the NOWDx HSV-2 Test based on comparison to the HerpeSelect 1 and 2 Immunoblot IgG and HerpeSelect 2 ELISA IgG assays. T...

Eligibility Criteria

Inclusion

  • Sexually active persons who self-select for syphilis testing n=750 participants; \~250 per study site Inclusion criteria: sexually active persons 18-64 years old Exclusion criteria: persons \<18 years old; persons \>64 years old; persons with limited or no reading skills; persons who previously participated in a NOWDx study
  • Expectant mothers n=90 participants; \~30 per study site Inclusion criteria: expectant mothers ≥18 years old Exclusion criteria: persons \<18 years old; persons with limited or no reading skills; persons who previously participated in a NOWDx study
  • Low prevalence population n=201 participants; \~67 per study site Inclusion criteria: persons aged 18-64 years old claiming to lack sexual experience Exclusion criteria: persons \<18 years old; persons \>64 years old; persons with limited or no reading skills; persons who previously participated in a NOWDx study
  • Lay users n=48 participants; \~16 per study site Inclusion criteria: persons 18-64 years old; ½ high risk sexual behavior; ½ low risk sexual behavior Exclusion criteria: persons \<18 years old; persons \>64 years old; persons with limited or no reading skills; persons who previously participated in a NOWDx study

Exclusion

    Key Trial Info

    Start Date :

    March 1 2023

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ACTUAL

    End Date :

    October 31 2023

    Estimated Enrollment :

    Patients enrolled

    Trial Details

    Trial ID

    NCT04294030

    Start Date

    March 1 2023

    End Date

    October 31 2023

    Last Update

    February 29 2024

    Active Locations (3)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (3 locations)

    1

    Clinical Research Consortium

    Tempe, Arizona, United States, 85283

    2

    Clinical Research of South Florida

    Coral Gables, Florida, United States, 33134

    3

    Alliance for Multispecialty Research Lexington

    Lexington, Kentucky, United States, 40509